BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37550827)

  • 21. Urethral luminal epithelia are castration-insensitive cells of the proximal prostate.
    Joseph DB; Henry GH; Malewska A; Iqbal NS; Ruetten HM; Turco AE; Abler LL; Sandhu SK; Cadena MT; Malladi VS; Reese JC; Mauck RJ; Gahan JC; Hutchinson RC; Roehrborn CG; Baker LA; Vezina CM; Strand DW
    Prostate; 2020 Aug; 80(11):872-884. PubMed ID: 32497356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: a biopsy study in chronic prostatitis patients.
    Vral A; Magri V; Montanari E; Gazzano G; Gourvas V; Marras E; Perletti G
    Int J Oncol; 2012 Dec; 41(6):1950-8. PubMed ID: 23026863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation.
    Wang W; Bergh A; Damber JE
    APMIS; 2009 Mar; 117(3):185-95. PubMed ID: 19245591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue.
    Parsons JK; Nelson CP; Gage WR; Nelson WG; Kensler TW; De Marzo AM
    Prostate; 2001 Sep; 49(1):30-7. PubMed ID: 11550208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer.
    Mani RS; Amin MA; Li X; Kalyana-Sundaram S; Veeneman BA; Wang L; Ghosh A; Aslam A; Ramanand SG; Rabquer BJ; Kimura W; Tran M; Cao X; Roychowdhury S; Dhanasekaran SM; Palanisamy N; Sadek HA; Kapur P; Koch AE; Chinnaiyan AM
    Cell Rep; 2016 Dec; 17(10):2620-2631. PubMed ID: 27926866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p16 Is upregulated in proliferative inflammatory atrophy of the prostate.
    Faith D; Han S; Lee DK; Friedl A; Hicks JL; De Marzo AM; Jarrard DF
    Prostate; 2005 Sep; 65(1):73-82. PubMed ID: 15880529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.
    Park JW; Lee JK; Phillips JW; Huang P; Cheng D; Huang J; Witte ON
    Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4482-7. PubMed ID: 27044116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma.
    Cheville JC; Bostwick DG
    Am J Surg Pathol; 1995 Sep; 19(9):1068-76. PubMed ID: 7544958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERG rearrangement is present in a subset of transition zone prostatic tumors.
    Falzarano SM; Navas M; Simmerman K; Klein EA; Rubin MA; Zhou M; Magi-Galluzzi C
    Mod Pathol; 2010 Nov; 23(11):1499-506. PubMed ID: 20693982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome is not associated with greater evidences of proliferative inflammatory atrophy and inflammation in patients with suspected prostate cancer.
    Russo GI; Cimino S; Giranio G; Regis F; Favilla V; Privitera S; Motta F; Caltabiano R; Stenzl A; Todenhöfer T; Morgia G
    Urol Oncol; 2018 May; 36(5):240.e21-240.e26. PubMed ID: 29429896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation.
    Casey OM; Fang L; Hynes PG; Abou-Kheir WG; Martin PL; Tillman HS; Petrovics G; Awwad HO; Ward Y; Lake R; Zhang L; Kelly K
    PLoS One; 2012; 7(7):e41668. PubMed ID: 22860005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
    Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
    J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-17 Expression by macrophages is associated with proliferative inflammatory atrophy lesions in prostate cancer patients.
    Vykhovanets EV; Maclennan GT; Vykhovanets OV; Gupta S
    Int J Clin Exp Pathol; 2011 Aug; 4(6):552-65. PubMed ID: 21904631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study.
    Weinmann S; Van Den Eeden SK; Haque R; Chen C; Richert-Boe K; Schwartzman J; Gao L; Berry DL; Kallakury BV; Alumkal JJ
    Prostate; 2013 Sep; 73(13):1371-7. PubMed ID: 23661613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer.
    Hoogland AM; Jenster G; van Weerden WM; Trapman J; van der Kwast T; Roobol MJ; Schröder FH; Wildhagen MF; van Leenders GJ
    Mod Pathol; 2012 Mar; 25(3):471-9. PubMed ID: 22080055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation.
    Wang W; Bergh A; Damber JE
    Prostate; 2007 Aug; 67(11):1238-46. PubMed ID: 17570496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-cell RNA-sequencing technology demonstrates the heterogeneity between aged prostate peripheral and transitional zone.
    Yan Q; Wang M; Xia H; Dai C; Diao T; Wang Y; Hou H; Zhang H; Liu M; Long X
    Clin Transl Med; 2022 Oct; 12(10):e1084. PubMed ID: 36245324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.
    Furusato B; Gao CL; Ravindranath L; Chen Y; Cullen J; McLeod DG; Dobi A; Srivastava S; Petrovics G; Sesterhenn IA
    Mod Pathol; 2008 Feb; 21(2):67-75. PubMed ID: 18065961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.
    Rodriguez-Teja M; Gronau JH; Breit C; Zhang YZ; Minamidate A; Caley MP; McCarthy A; Cox TR; Erler JT; Gaughan L; Darby S; Robson C; Mauri F; Waxman J; Sturge J
    J Pathol; 2015 Mar; 235(4):581-92. PubMed ID: 25408555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.